Document is current
Any future updates will be listed below
-
Authors
Wu, Ting-Shuan
Hsiao, Tzu-Hung
Chen, Chung-Hsing
Li, Hsin-Ni
Hung, Miao-Neng
Jhan, Pei-Pei
Tsai, Jia-Rung
Teng, Chieh-Lin Jerry
-
Funding
Funding for this research was provided by:
Taichung Veterans General Hospital (TCVGH-1133701D)
National Science and Technology Council (NSTCNSTC 112-2314-B-005-011)
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 14 January 2025
First Online: 21 January 2025
Declarations
:
: This study was approved by the Institutional Review Board of the Taichung Veterans General Hospital following the latest version of the Declaration of Helsinki (CF17319B). All the participants provided informed consent before participating in the study. The patient details were anonymized.
: We confirm that the material is original research, has not been published elsewhere in part or in entirety and is not under consideration by another journal. All authors have approved the manuscript and agree with its submission to Clinical Proteomics.
: Chieh-Lin Jerry Teng received honorarium and consulting fees from Novartis, Roche, Pfizer, Takeda, Johnson and Johnson, Amgen, BMS Celgene, Kirin, and MSD. The other authors have no conflicts of interest.
